Concepedia

Polymorphisms in transporter and phase II metabolism genes as potential modifiers of the predisposition to and treatment outcome of de novo acute myeloid leukemia in Israeli ethnic groups

Phillip Müller, Nava Asher, Maya Heled, Sara Bar Cohen, Angela Risch, Deborah Rund

Leukemia Research · 2008 · 54 citations · 37 references

DOI

Concepts

References

37

C421A polymorphism in the human breast cancer resistance protein gene is associated with low expression of Q141K protein and low-level drug resistance.

Yasuo Imai, Minoru Nakane, Kumie Kage et al. · PubMed · 2002 · 441 citations

, , +17

Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2

Shinji Mizuarai, Naohiko Aozasa, Hidehito Kotani · International Journal of Cancer · 2003 · 317 citations

, , +17

The breast cancer resistance protein (Bcrp1/Abcg2) restricts exposure to the dietary carcinogen 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine.

Antonius E. van Herwaarden, Johan W. Jonker, Els Wagenaar et al. · PubMed · 2003 · 237 citations

, , +14

Identification of BCRP as transporter of benzo[ a ]pyrene conjugates metabolically formed in Caco-2 cells and its induction by Ah-receptor agonists

Bettina Ebert, Albrecht Seidel, Alfonso Lampen · Carcinogenesis · 2005 · 216 citations

, , +12

Gene expression profiling of adult acute myeloid leukemia identifies novel biologic clusters for risk classification and outcome prediction

Carla S. Wilson · Blood · 2006 · 190 citations · Full text

, , +17